PCNA and breast carcinoma: PCNA downregulation by skimmianine may disrupt DNA replication and cell cycle progression, reducing its proliferative potential and limiting tumor growth, consistent with studies showing that targeting PCNA can inhibit DNA replication in breast cancer cells [13].